Clinical Trials Browser

Phase 2 × INDUSTRY × cositecan × Clear all

NCT00062478 2020-03-12

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Phase 2 Completed

Brain Neoplasms

NCT00062491 2020-03-12

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

Phase 2 Completed

Melanoma, Neoplasms